EP1102865A2
|
|
Methods and compositions for modulating "marginally indiscriminant" hybridizations
|
WO9963077A2
|
|
Compositions of nucleic acid which alter ligand-binding characteristics and related methods and products
|
WO9963074A2
|
|
Altering the ligand-binding characteristics of a nucleic acid ligand binding sequence by altering the nucleotide composition of its flanking sequences
|
WO9963117A1
|
|
Method of creating flanking polynucleotide sequences which convey relative binding affinities to a ligand binding site
|
WO9942621A2
|
|
Methods for identifying or characterising a site based on the thermodynamic properties of nucleic acids
|
EP1042510A1
|
|
Method of selecting flanking sequences which convey relative binding affinities to a ligand binding site
|
US6221589B1
|
|
Methods and compositions for modulating melting temperatures of nucleic acids
|
EP1007735A1
|
|
Anti-sense oligonucleotide pharmacological agents
|
WO9837241A1
|
|
Telomerase extension assay
|
EP0975795A1
|
|
Process for selecting anti-sense oligonucleotides
|
CA2259918A1
|
|
Signal amplification method
|
US5770365A
|
|
Nucleic acid capture moieties
|